FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

RIGEL PHARMACEUTICALS, INC.: operating_income

One fact, its scope and the complete path back to the official record.

Period: 2016-01-01 – 2016-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/0d49d63c-1654-4a2b-876b-cfe406802bb7

Reported value

$-69.741M{"amount": -69741000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Entity
RIGEL PHARMACEUTICALS, INC.
Metric
operating_income
Period
2016-01-01 – 2016-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001558370-17-001428 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T10:04:01.316986+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001034842/operating-income/2016-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.